ERBB2 and breast carcinoma: On the same grounds, ongoing efforts have been directed towards uncovering whether HER2-low-positive tumors may retain possible unique traits5–7, however, so far, solid evidence supporting HER2-low-positive breast cancer as a distinct biological and/or clinical entity is lacking.